The Pharmacology of a New Antiestrogen
Presently, attempts to pharmacologically antagonize estrogen action are impeded by the weak estrogenic activity of the currently available estrogen antagonists. Most antiestrogens, rather than being pure antagonists, possess varying degrees of estrogen agonist activity. Thus, the action of estrogens can be antagonized only to the point where the agonist activity of the antiestrogen begins to be expressed.
KeywordsMammary Tumor Estradiol Benzoate Relative Binding Affinity Estradiol Benzoate Pure Antagonist
Unable to display preview. Download preview PDF.
- 3.Gale K: Treatment of advanced breast cancer with aminoglutethimide. Cancer Res suppl (42): 3389–3396, 1982.Google Scholar